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Abstract
Introduction: A promising compound for the treatment of inflammatory periodontal diseases is benzofuracaine (BFC). 
BFC has pronounced anti-inflammatory, analgesic, reparative, hypoglycemic and other effects. Objective: To assess 
the influence of benzofuracaine on experimental periodontitis and to study its antidiabetic activity and molecular mech-
anisms of action
Materials and methods: The work was performed on 232 white nonlinear rats of both sexes and 55 male mice. To 
assess the effect of BFС on experimental periodontitis, the amount of gingival fluid (AGF) was determined, an in-depth 
morphofunctional study of periodontal tissues was conducted, as well as the study of the biochemical composition of 
the gingiva and blood. Antidiabetic properties were studied using the glucose tolerance test (GTT), as well as the as-
sessment of endothelium-dependent vasodilation and transmembrane K+-currents on an isolated aortic segment of rats 
with streptozotocin-induced diabetes mellitus (DM).
Results and discussion: In experimental periodontitis, BFC improves the morphological picture and decreases AGF, in-
creases the level of blood microcirculation in the attached gingiva, has a normalizing effect on the prekallikrein-kallikrein 
system, reduces the synthesis of bradykinin, proinflammatory cytokines and PGE2, increases the level of VEGF, reduces the 
level of endothelin-1, increases the ATP content and NADH-ubiquinone-reductase activity, exhibits antioxidant properties, 
reduces the content of nitrosothiols and NO metabolites (NO2/NO3), increases the level of transferrin; when conducting a 
glucose tolerance test in mice, it reduces the level of glucose in the blood, but in this respect is inferior to glibenclamide, has 
a hypoglycemic effect in the early stages of diabetes (30 days), tends to restore endothelium-dependent dilatation of smooth 
muscle cells (SMC) of the aorta and does not affect the functioning of the K+-channels of the aortic SMC.
Conclusion: BFС is an effective drug for the treatment of periodontitis and can be recommended for further preclinical 
and clinical studies.
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Introduction
Pathology of periodontal tissues is a major problem in 
modern dentistry. Periodontitis dominates in the group of 
inflammatory diseases. Patients of any age can be affected 
by this disease, and the pathological process itself tends to 
be chronic (Kaner et al. 2009, Petersen et al. 2016).
The prevalence of chronic generalized periodontitis ranks 
second in the structure of dental pathology after caries 
(Petersen and Ogawa 2012).
The etiological factors underlying periodontitis are 
represented by a wide range of genetic, epigenetic, 
immunological, and microbiological disorders (Hajis-
hengallis 2014, Hajishengallis 2015, Laine et al. 2012, 
Larsson et al. 2015, Rettori et al. 2014, Silva et al. 2015).
Periodontitis occurs in almost 100% of cases in pa-
tients with diabetes mellitus (DM) GJU (Lalla 2007) 
and is characterized by a pronounced aggressive course, 
specific morphological features of the lesion and high 
resistance to pharmacotherapy. The development of the 
pathogenetically sound principles for the treatment of in-
flammatory periodontal diseases against the background 
of diabetes remains an urgent task of modern dentistry 
(Ide et al. 2011, Preshaw et al. 2012, Zhou et al. 2015).
For the implementation of complex pharmacotherapy 
of periodontitis, various pharmacological drugs are used, 
among which are both nonsteroidal antiphlogistics and 
hypoglycemic drugs in case of diabetes, but they do not 
always result in the desired therapeutic effect, and some-
times can cause various side effects (Renvert and Persson 
2016, Salvi and Lang 2005, Zandbergen et al. 2016).
Recently, much attention has been paid to the use of 
multitarget drugs, which are capable of specifically mo-
dulating several biological targets with one molecule. 
(Anighoro et al. 2014, Bansal and Silakari 2014). In this 
regard, of great interest is the Russian drug Benzofuro-
caine (BFC) – ethyl 4-chloro-6-[(dimethylamino)met-
hyl]-5-hydroxy-2-methyl-1-benzofuran-3-carboxylate. 
This compound has obvious anti-inflammatory (mainly, 
antikinin) and analgesic (peripheral and central) effects, 
exhibiting local anesthetic, antiarrhythmic and antiangi-
nal properties, stimulating the processes of proteosyn-
thesis, tissue respiration and oxidative phosphorylation, 
which has an antioxidant effect, with a positive effect on 
microcirculation; predetermines a decrease in blood sugar 
levels; has neither ulcerogenic nor nephrotoxic actions 
(Bedrosova et al. 2013, Bedrosova et al. 2015, Lebedev et 
al. 1989, Ornostaĭ and Stepaniuk 1991).
These data served as the basis for studying the effect 
of BFC on the course of periodontitis against the back-
ground of normal and hyperglycemia caused by experi-
mental (streptozotocin-induced) DM.
Objective: to assess the influence of benzofuracaine 
on experimental periodontitis and to study its antidiabetic 
activity and molecular mechanisms of action
Materials and methods
The study was performed on 232 white nonlinear rats 
of both sexes, each weighing 190–390 g, and 55 male 
mice of 20–26 g each. The work complied with the re-
quirements of the Law of the Russian Federation “On the 
Protection of Animals Against Cruel Treatment” of June 
24, 1998, Good laboratory practice rules for preclinical 
studies in the Russian Federation (GOST 3 51000.3-96 
and GOST R 53434-2009), Directives of the European 
Community (86/609 EC), the international recommenda-
tions of the European Convention for the Protection of 
Vertebrate Animals Used in Experimental Studies (1997) 
and the Laboratory Rules adopted in the Russian Federa-
tion (Order of the Ministry of Healthcare of the Russian 
Federation № 708 of 29.08.2010).
All the manipulations, species and the number of ani-
mals were approved by the local Bioethical Committee 
(Minutes No. 06-07/02-1).
Modeling of experimental periodontitis (EP) was per-
formed according to the method described by A.M. Pol-
son et al. (1983) and G.C. Keles et al. (2005). EP was 
created by applying tight ligatures on the gums under 
zolazepam-induced anesthesia (Zoletil by Virbac Sante 
Animale, France) (Fig. 1). Animals were monitored daily, 
from Day 43 to Day 61 after the start of the experiment. 
A comparative study of the effects from the standard the-
rapy (ST) and from the combination of ST with BFC 
on periodontal tissues and the amount of gingival fluid 
(AGF) in rats with EP AGF was determined by the in-
trasulcular method by N. Brill and B. Krasse (1958). A 
Schiller-Pisarev test was made (Nágel et al. 1970).
ST included oral irrigation with chlorhexidine dig-
luconate (0.05%), intraperitoneal (ip) injection of linco-
mycin hydrochloride (0.1 ml/100 g), application of perio-
dontal dressings (anesthesin – 1.0 g; methyluracil – 0.5 g; 
metronidazole – 0.25 g; carotolin – 1.0 ml; water dentine 
– 1.0 g). The course of ST was 12 days.
BFC was introduced into the composition of periodon-
tal dressings, and also injected to the animals at a dose of 
10 mg/kg. The course of administering BFC was 12 days.
A study of the effect of BFC on the state of capillary blood 
flow in the gingival mucosa against the background of EP 
was carried out on 50 anesthetized (urethane 1.1 g/kg ip) rats. 
In the study of microcirculation, Laser Doppler flowmetry 
(LDF) was used (Krupatkin and Sidorov 2013). A light guide 
probe was fixed in a silicone splint for the lower incisors and 
placed on the attached gingiva (AG) on the labial side. The 
measurement time was 1 min. The average blood flow (M) 
was recorded under conditions of a healthy periodontium 
before administration of BFC at a dose of 10 mg/kg (ip) and 
then 5, 10, 20, 40, and 60 min after its administration.
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EP was modeled according to the method described by 
A.M.Polson et al. (1983) and G.C.Keles et al. (2005). The 
animals were randomized into 4 groups.
1) Intact –  with a healthy periodontium (n = 10)
2)	 Control – with EP without treatment (12 days, isoto-
nic NaCl solution was injected ip) (n = 10)
3)	 Group	of	ST – with EP and ST (12 days) (n = 10)
4)	 Group	 of	 ST+BFC – with EP and administering 
ST+BFC (BFC was used according to the method de-
scribed above) (n = 10)
The parameters of the basal blood flow (M) were re-
corded before modeling EP, on Day 31 (against the back-
ground of established EP), Day 44 (after 12 days of treat-
ment) and Day 74 (1 month after treatment). At the same 
time intervals, microcirculation was also studied in ani-
mals with a healthy periodontium.
Effect of BFC on the activity of kallikrein-kinin, immune 
and endothelial systems with EP was studied on 33 rats:
1) Intact – without EP (n = 11);
2	 Control – on Day 30 after simulating EP, the saline 
solution (in the equivalent volume) was injected ip 
once a day (n = 11);
3)	 Group	of	BFC – on Day 30 after simulating EP, BFC 
was injected at a dose of 10 mg/kg, also once a day. 
The efficacy of BFC was evaluated 10 days after the 
administration (n = 11).
In the homogenates of the gingiva, the content of en-
dothelin-1 was determined, using the test system by R&D 
Systems for Human Endothelin-1 Immunoassay (UK), 
and that of the vascular endothelial growth factor (VEGF) 
by means of a VEGF ELISA Kit (Quantikine human 
VEGF; R&D Systems, Minneapolis MN, USA).
The activity levels of kallikrein and prekallikrein were 
evaluated by a spectrophotometric method according to 
the rate of hydrolysis of N-α-benzoyl-L-arginine ethyl es-
ter (Paskhina et al. 1974).
The level of prostaglandin E2 (PGE2) was determined 
using an ELISA kit (Enzo Life Science, USA), sensitivity 
13.4 pg/ml of PGE2, measuring range 39.1-2.500 pg/ml.
Plasma bradykinin concentration was determined by 
the enzyme immunoassay method (Enzyme Immunoassay 
system Bradykinin kit, Peninsulda Lab., Inc. California, 
USA), and concentration of thromboxane A2 – by ELI-
SA method using kits by Assay Designs Correlate-EIA™ 
Thromboxane B2.
A study of the effects of BFC on hypoxic syndrome, 
oxidative stress and nitric oxide metabolism under 
EP conditions was performed on 30 rats. The methods 
to simulate EP, to determine intracellular ATP, activity 
of succinate-ubiquinone-reductase and NADH-ubiqui-
none-reductase systems, the content of cytochrome C, 
lactate and pyruvate, the content of O2 by measuring the 
inhibition of cytochrome C reduction by superoxide dis-
mutase (SOD); the rate of Н2О2formation using the fluo-
rescent method and malonic dialdehyde (MDA), as well 
as to record the electron paramagnetic resonance (EPR) 
spectra on the RE-1307 radio spectrometer (Russia) were 
used according to Danhier and Gallez (2015), Keles et al. 
(2005), Polson and Zander (1983).
Determination of NO metabolites (NO2/NO3) in blood 
was performed spectrophotometrically by excretion of 
stable metabolites (ЕNOx) with prior deproteinization 
Figure 1. Modeling of EP by applying ligatures on the gum adjacent to incisors
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of serum and reduction of NO3- to NO2- using granulated 
cadmium (Golikov and Nikolaev 2004).
All rats after EP simulation were randomized into 2 
groups, control and experimental. To the animals of the 
control group (n = 10) on Day 30 after EP simulation, nor-
mal saline was administered (in the same volume as BFC), 
in the experimental group (n = 10), BFC was injected ip at 
a dose of 10 mg/kg once a day, and its efficacy was studied 
in periodontal homogenates 10 days after injection.
A comparative study of the effect of ST and combination 
of ST with BFC on the morphofunctional state and re-
generation of damaged gingival tissues during EP was 
carried out on 45 anesthetized (urethane 1.1 g/kg ip) rats. 
The animals were randomized into 3 groups:
Control – with EP without treatment (n = 15)
Group	of	ST – with EP with 14-day course of ST (n = 15)
Group	 of	 ST+BFC – with EP with 14-day course of 
ST+BFC (n = 15).
Biopsy sampling of tissues from the marginal gingival 
area in rats with EP was performed before treatment and 
28 days after the start of treatment.
The biopsy material was fixed in a 10% solution of 
neutral formalin and embedded in paraffin. Paraffin secti-
ons were stained using the following dyes and methods: 
hematoxylin and eosin; Mallory’s method; alcyanic blue 
(at pH 1 and 3), toluidine blue; the PAS alcyan blue me-
thod (Lilly 1969) and Hotchkiss-McManus’ method, with 
hematoxylin staining cell nuclei. In addition, the methods 
of combined staining were used: by aldehyde-fuchsin, 
chromotrope and aniline blue, alcian blue and neutral red.
In order to increase the objectivity of the results of 
the study, morphometry was used, which was performed 
using a stereometric counting grid. At the same time, the 
relative area occupied by inflammatory cell infiltrates, 
areas of sclerosis, as well as the area restored via restituti-
on (complete regeneration) were determined. Assessment 
of vascularization of the regenerate was carried out by de-
termining the percentage of the area of the own gingival 
plate with blood vessels.
A comparative study of hypoglycemic activity of BFC 
and glibenclamide on the model of glucose toleran-
ce test (GTT) was performed on 55 mice. To determine 
hypoglycemic properties in BFC, a model of glucose to-
lerance test was used, by means of a single subcutane-
ous injection of 40% aqueous glucose solution (3 g/kg) 
(Buzlama et al. 2013). Control and experimental animals 
were deprived of food for 12 hours. Sixty minutes prior to 
conducting the glucose tolerance test, 1% aqueous soluti-
on of BFC was once administered ip to the animals of the 
experimental group at the doses of 5 and 10 mg/kg. To the 
animals of the comparison group Glybenclamide was in-
tragastrically administered once at a dose of 0.36 mg/kg. 
The glucose concentration (mmol/L) in blood was measu-
red using a Bionime Rightest GS300 electronic glucose 
meter (Bionime Gmbh, Switzerland) several times: 1) 5 
times before drug administration; 2) after administration 
of drugs before injecting glucose; 3) 30, 60 and 120 mi-
nutes after the administration of glucose. In the control, 
glucose concentrations were measured 4 times - on an 
empty stomach, before glucose administration, and 30, 
60, and 120 minutes after it.
Then, A.A. Pokrovsky’s coefficient (C) was calculated 
(Buzlama et al. 2013) – the ratio of the difference between 
the maximum and initial levels of glucose in blood to the 
original level, expressed in %, according to Formula 1.
Formula 1. The calculation of A.A. Pokrovsky’s coefficient
C  =  (В–А)/А × 100 (1),
where A is the initial glucose level, B is the maximum 
glucose level.
A study of the antidiabetic properties of BFC, its effects 
on endothelial dysfunction and aortic K+-chanellopathy 
was performed on 40 rats. Diabetes was modeled using 
a single injection of Streptozotocin (65 mg/kg ip, once). 
Streptozotocin was dissolved in citrate buffer solution 
containing 0.9% NaCl and 10 mmol of citrate, pH = 4.6. 
In the experiment, the animals were used on 30±7 and 
90±7 days after the induction of diabetes.
The glucose levels of the control (n = 8) and diabetic 
rats (n = 32) were measured before injection of streptozo-
tocin every 30 days for 3 months of diabetes development 
and on the day of the experiment using a Bionime Right-
est GS300 electronic glucose meter (Bionime Gmbh, 
Switzerland). With administering BFC to diabetic rats (n 
= 16), the glucose level was measured daily in all groups 
of animals. BFC was injected im at a dose of 15 mg/kg in 
the early (30 days, n  =  8) and late (90 days, n = 8) periods 
of development of diabetes. BFC (200 μl) was injected 
twice a day for 5 days.
Registration	 of	 vascular	 tone	was conducted on the 
prepared segments of the thoracic aorta. After pre-anes-
thesia (ketamine 45 mg/kg, xylazine 10 mg/kg), the an-
imals were euthanized by decapitation. The thorax was 
opened, the aorta was isolated and transferred to Krebs 
solution at a temperature of 18–23° C. For animals with 
diabetes, the glucose concentration in the solution was 
increased to 25 mmol/l. The thoracic aorta was cut into 
circular segments, 1–2 mm wide.
Registration of contractile activity of vascular prepa-
rations was performed in isometric mode using voltage 
sensors (Danish Myo Technology, Aarhus, Denmark) and 
the LabScribe 2 software (World Precession Instrument 
Inc., USA).
To determine endothelium-dependent vasodilation, 
acetylcholine (AC) was used at a concentration of 10–10–
10–4 M for preparations previously contracted by means 
of phenylephrine (PE) at a concentration of 10–6 M. 
The values of the average effective concentration of AC 
are shown as a negative logarithm of AC concentration 
necessary for the development of a half-maximal response 
(pD2). This parameter was calculated using Formula 2.
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Formula 2. Calculation of AC average effective concen-
tration.
Т  =  100 / (1 + 10 Log	(x0 – x) × р) (2),
where T is the normalized level of tone (% of the initial 
level of contraction), x is the concentration of the test sub-
stance (expressed as negative logarithm), x0 is the middle 
point of the dose-response curve (i.e. T = 50%) and p is 
the curve slope factor. The pD2 totals were obtained by 
averaging pD2 calculated separately for each vascular 
preparation.
Transmembrane	 K+-currents	 were studied using the 
method of fixing the membrane potential (patch-clamp) in 
the modification “whole-cell perforated patch”. SMC of 
vessels were isolated from the prepared thoracic aorta of 
rats. Ion currents were recorded and cells were stimulated 
using an Axopatch 200B amplifier (Axon Instruments 
Inc., USA), a Digidata 1200B analog-to-digital converter 
(ADC) (Axon Instruments Inc., USA) and pClamp Soft-
ware (V.6.02, Axon Instruments Inc., USA).
Statistical processing of research results was carried out 
using the tables of the mean error values and the confi-
dence interval of the arithmetic mean value of the varia-
tion series using Student’s t-test for paired and unpaired 
measurements (Dakhale et al. 2012, Glantz 2005), pack-
ages of licensed applications – Statistica 10.0, Origin 8.1 
(OriginLab Corporation, USA), EXCEL 5.0 (Microsoft, 
USA) and Microsoft Office Professional Plus 2013; the 
differences were taken as significant at p£0.05.
Anesthesia and reference drugs:
– Zoletil – 6% solution, 60 mg/kg ip (Virbac Sante Ani-
male, France)
– Anesthezin – 1.0 g as part of the solution for gingival 
dressings (Pharmstandard-Ufa, Russia)
– Xylazine (Xyla) – 2% solution, 10 mg/kg ip (Inter-
chemie, Netherlands)
– Ketamine – 5% solution, 45 mg/kg ip (Moscow En-
docrine Factory, Russia)
– Methyluracil – 0.5 g as part of the solution for gingi-
val dressings (Veropharm, Russia)
– Metronidazole – 0.25 g as part of the solution for gin-
gival dressings (Galderma Labarotory, France)
– Carotoline – 1.0 ml as part of the solution for gingival 
dressings (Biostimulator LLC, Ukraine)
– Aquatic dentin – 1.0 g as part of the solution for gingival 
dressings (STOMADENT LLC, Russia)
– Chlorhexidine digluconate – 0.05% solution for irrigati-
on (ROSBIO LLC, Russia)
– Lincomycin hydrochloride – 0.1 ml/100 g ip (Omela 
LLC, Ukraine)
– Glibenclamide (Maninil®) – 0.37 mg/kg ig (Berlin-Che-
mie AG/Menarini Group, Germany)
– Urethane (Diprivan®) – 1% solution, 1.1 g/kg ip (Astra-
Zeneca UK Ltd, UK)
Results and discussion
A comparative study of the effect of ST and the com-
bination of ST with BFC on the state of periodontal 
tissues and AGF in rats with EP
In rats with EP, the combination of ST+BFC showed the 
most pronounced therapeutic effect both in the immedia-
te and distant periods of observation, which significantly 
exceeded only ST. The Schiller’s test was negative in all 
animals. AGF on Day 44 of the experiment decreased 2.6 
times as compared with Day 31 and was close to the ini-
tial ones (Table 1). 
After one month (on Day 74 of observation), phar-
macotherapy (BFC+ST) showed that periodontal tissues 
in rats with EP did not differ much from their conditi-
on in the group of intact animals. In the group of rats 
where only ST was used, the symptoms of the patholo-
gical process (edema, hyperemia of the marginal edge, 
discharge from the gingival pockets) persisted in most 
animals.
Effect of BFC on the state of capillary blood flow in 
the gingival mucosa in healthy periodontium and in 
rats with EP
The	 effect	 of	 BFC	 on	 the	microcirculation	 in	 a	 healthy	
periodontium.	At the intervals of 5, 10, 20 and 40 min-
Table 1. Effect of ST and Combination of ST with BFC on AGF in Rats with EP (M±m)
Type of impact, number of rats AGF, mg 
Before simulation Day 31 of Experiment Day 44 of Experiment
1. Intact periodontium (n = 10) 0.024±0.002 0.024±0.002 0.024±0.001
2. Periodontitis without Treatment (n = 10) 0.024±0.002 0.082±0.004 0.091±0.006*
р1-2<0.001 р1-2<0.01
3. Periodontitis+SТ (n = 10) 0.024±0.002 0.084±0.002* 0.053±0.001*
р1-3<0.001 р1-3<0.001
р2-3>0.5 р2-3<0.001
4. Periodontitis+SТ+ BFC (n = 10) 0.024±0.006 0.089±0.003* 0.034±0.005
р1-4<0.001 р1-4> 0.05
р2-4>0.1 р2-4<0.001
р3-4>0.1 р3-4<0.02
Note: * p<0.001 - in relation to the data in intact control; p<0.001 – in relation to the data before treatment, i.e. on day 31 of the experiment.
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utes after the injection of BFC, the capillary perfusion 
decreased significantly. So, M at the above time inter-
vals was 19.9±0.2, 17.6±0.2, 19.1±0.3 and 20.4±0.3 P.U., 
which is statistically significantly (p<0.001 in all cases 
except M at the 40th minute, for which p <0.02) lower – 
7.0, 17.8, 10.7 and 7.0% lower than the initial value of 
21.4±0.2 P.U. The most pronounced decrease in M was 
noted at the 10th minute of the study. By the 60th minute 
of the experiment, M was almost comparable with those 
at the outcome.
The	effect	of	BFC	on	microcirculation	in	AG	in	condi-
tions	of	EP. It was revealed that in animals with a healthy 
periodontium (intact) microcirculation parameters in the 
AG area were almost stable, as evidenced by the absence 
of statistically significant differences between the initial 
data and data on Days 31t, 44 and 74 of the study: M was 
within the range of 21.8-22.4 (Table 2).
In the control group of animals on Days 31, 44, and 
74, M was significantly (p<0.001 in all cases) – 37.1, 
39.7, and 43.2 – lower than the outcome (22.9 P.U.) 
(Table 2).
The use of ST for 12 days in case of EP caused signifi-
cant increase in M in animals M. So, on Day 44 and Day 
74 of the study, M statistically significantly (p <0.001 in 
all cases) increased by 26.6 and 20.9. At the same time, M 
on Day 74 of the study, compared with that in Day 44, sig-
nificantly (p<0.05) decreased by 4.5%. However, the posi-
tive changes in the microcirculation that occurred did not 
reach its baseline at any time during the study (Table 2).
When using the combination of ST+BFC in the condi-
tions of EP, more significant changes in M were observed 
than was the case when only ST was used. So, on Day 44 
and Day 74 of the study, the average level of microcircu-
lation was statistically significant (p<0.001) increased by 
40.8 and 53.5% (Table 2).
When comparing the parameters of microcirculation in 
AG of 4 groups of animals with one another, it was found out 
that the outcomes of M were almost comparable (Table 2).
Table 2. Effect of ST and Combination of ST+BFC on the State of Microcirculation (M, P.U.) in the AG Area of the Lower Incisors 
of Rats (M±m, n = 10)
Initial data Day of experiment
31; with EP 44; with EP after 12-day treatment 74; with EP after 1-month treatment
Intact
22.4 ± 0.3 22.0 ± 0.3 21.8 ± 0.2 22.2 ± 0.2
р1-2 > 0.05 р1-3 > 0.05 р1-4 > 0.05
[-1.8] [-2.7] [-0.9]
р2-3 > 0.05 р2-4 > 0.05
[-0.9] [+0.9]
р3-4 > 0.05
[+1.8]
Control
22.9 ± 0.3 14.4 ± 0.2+++ 13.8 ± 0.3+++ 13.0 ± 0.3+++
р1-2 < 0.001 р1-3 < 0.001 р1-4 < 0.001
[-37.1] [-39.7] [-43.2]
р2-3 > 0.05 р2-4 > 0.002
[-2.1] [-9.7]
р3-4 > 0.05
[-5.8]
Group ST
21.8 ± 0.2 13.9 ± 0.3+++ 17.6 ± 0.2+++ххх 16.8 ± 0.3+++ххх
р1-2 < 0.001 р1-3 < 0.001 р1-4 < 0.001
[-36.2] [-19.3] [-22.9]
р2-3 < 0.001 р2-4 > 0.001
[+26.6] [+20.9]
р3-4 < 0.05
[-4.5]
Group ST+BFC
22.3 ± 0.3 14.2 ± 0.2+++ 20.0 ± 0.3+++ххх*** 21.8 ± 0.3ххх***
р1-2 < 0.001 р1-3 < 0.001 р1-4 > 0.05
[-36.3] [-10.3] [-2.2]
р2-3 < 0.001 р2-4 < 0.001
[+40.8] [+53.5]
р3-4 < 0.001
[+9.0]
Note: The differences are statistically significant relative to: + - healthy periodontium, x- periodontitis without treatment, * - periodontitis with use 
of ST; three signs - p <0.001.
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Effect of BFC on the activity of kallikrein-kinin, im-
mune and endothelial systems in EP in rats
The course of EP is accompanied by activation of the 
prekallikrein and a 45% increase in kallikrein. Course ad-
ministration of BFC leads to inhibition of the synthesis 
of kallikrein by 23%, which is not observed in the con-
trol group of animals. At the same time, the content of 
prekallikrein increases by 22% relative to the group with 
EP and by 15.5% relative to the norm, which is a factor 
confirming a decrease in the formation of inflammation 
mediator bradykinin. Moreover, its level is reduced by 
10.4%, but exceeds the control by 25% (Table 3).
In the course of the study, it was established that the 
content of pro-inflammatory interleukins increases in 
periodontal tissues, the content of IL-1β increases by 9%, 
TNF-α – by 21%, inflammatory mediator PGE2 – by 40%, 
which is a consequence of activation of cyclooxygenase-2 
(COX-2).
A decrease in the content of TNF-α to the norm and 
PGE2 by 18% relative to the model of EP shows the acti-
vation by BFC of reparative processes in periodontal tis-
sues and the reduction of the pain effect. At the same time, 
BFC does not affect the activity of COX-1, since the level 
of thromboxane A2, which is 31% higher with EP, does 
not change significantly. A close relationship between the 
PGE2 level and bradykinin was also established (r = 0.8, 
p<0.001).
The course application of BFC normalizes the level of 
the vasoconstrictor component of endothelin-1 (decreas-
es by 50%) and activates VEGF by 64% relative to the 
norm. Such an increase in VEGF expression, along with 
a decrease in the level of IL-1β and TNF-α (by 21%) is 
considered as markers of lymphogenesis.
Effect of BFC on hypoxic syndrome, oxidative stress 
and nitric oxide metabolism  in rats with EP
Under the influence of BFC, the content of ATP, which 
was  26% lower in EP, increased by 15%, though  there 
were no changes in the 20%-reducedcontent of cytochro-
me C, the activity of succinate dehydrogenase (SDH) and 
succinate-ubiquinone-reductase, and a 76% increase in 
NADH-ubiquinone-reductase. The content of pyruvate 
more than doubled relative to the level observed in EP, 
and was two times higher than its content in normal tis-
sue. The content of lactate under the influence of BFC 
increased by only 29%. Consequently, BFC dramatically 
activates aerobic glycolysis with the constant lactate/py-
ruvate ratio (Table 4).
Under the influence of BFC, a decrease in O2 generati-
on rate by 15%, in H2O2 by 22%, in nitrosothiols by 13% 
and positive changes in the EPR signal against a 14% of 
NO (NO2/NO3) metabolites , as well as the absence of 
significant changes in MDA level indicates the ability of 
BFC to shift the imbalance in the pro-/antioxidant system 
towards the latter and the preparation having a pronoun-
ced antioxidant activity. An elevated level of NO metabo-
lites has an adaptation value, since it can be an indicator 
of a decreased intensity of endothelium dysfunction, es-
pecially against the background of the normalization of 
half-width and EPR signal intensity, as well as a decrease 
in endothelin-1 (Table 4).
A comparative study of the effect of ST and combinati-
on of ST with BFC on the morphofunctional state and 
regeneration of damaged gingival tissuesin rats with EP
During the morphological study of biopsy specimens of 
the mucous membrane of the gingiva of animals with 
EP in the acute period of the disease, there were changes 
both in the epithelial covering of the gingiva and in its 
connective tissue basis  (Fig. 2). In the gingival lamina	
propria,there was edema, circulatory disorders, fibrinoid 
changes in the walls of blood vessels and connective tis-
sue structures, as well as  massive inflammatory cellular 
infiltrate, in which mast cells were detected. The presence 
of neutrophilic leukocytes in the infiltrate characterized 
the intensity of the inflammatory process. It should be 
noted that inflammatory cellular infiltrates did not occupy 
the entire territory of the lamina	propria. There were al-
ways areas free of infiltrates not only in the papillary, but 
also in the reticular layers.
The epithelial covering of the gingiva (Figs. 3 and 4) 
suffered from acanthosis, often alon with the thickening 
and lengthening of acantotic processes that go deep into 
Table 3. Effect of BFC on the Activity of Kallikrein-kinin, Immune and Endothelial systems in rats with EP (M±m, n = 11)
Marker Intact Control (Periodontitis) Periodontitis + BFC
Tromboxan A2, ng/ml 427.0 ± 36.0 561.0 ± 82.0 531.0 ± 47.0
PGE2, ng/ml 18.4 ± 0.6 25.8 ± 2.0** 21.2 ± 1.1*
Prekallikrein, µmol/ml per hour 71.0 ± 3.0 67.0 ± 4.0 82.0 ± 4.0*°
Kallikrein, mU/l 62.0 ± 4.0 90.0 ± 4.0*** 69.0 ± 3.0°°°
Bradykinin, ng/ml 5.5 ± 0.2 7.7 ± 0.2*** 6.9 ± 0.3*°
IL-1β, pg/ml 4.8 ± 0.3 5.25 ± 0.35 4.6 ± 0.3
TNF-α, pg/ml 10.8 ± 0.4 13.1 ± 0.6** 10.7 ± 0.5°
Endothelin-1, fg/ml of protein 1.30 ± 0.08 2.58 ± 0.27*** 1.25 ± 0.09°°°
EGF, fg/ml of protein 81.0 ± 11.0 104.0 ± 15.0 133.0 ± 9.0**
Note: reliability of differences in average values: when compared with the group indicator, the norm (control 1) – *p<0.05, **p<0.01, ***p<0.001; 
when compared with the indicator group control 2 (periodontitis) – °p<0.05, °°p<0.01, °°°p<0.001.
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Table 4. Effect of BFC on the Indicators of Energy Supply, Oxidative Stress and NO Metabolism in rats with EP (M±m, n = 10)
Marker Intact Control (Periodontitis) Periodontitis +BFC
Level of NO metabolites in plasma (nitrites/nitrates), µmol/L 12.3 ± 0.6 17.2 ± 0.6*** 15.2 ± 0.5**°
Nitrosothiol content, µmol/g of protein 16.6 ± 0.5 23.1±0.8*** 20.2±0.8**°
O2- generation rate 1.98 ± 0.21 7.58±0.41*** 6.44±0.27***°
Hydrogen peroxide, H2O2 1.52 ± 0.12 5.55±0.18*** 4.63±0.25***°°
Signal intensity 23.8 ± 0.9 15.6±0.6*** 20.2±0.8*°°°
Half width of signal 6.9 ± 0.3 4.2±0.3*** 5.3±0.3*°
FeS, g = 1.54 37.0 ± 2.0 32±1* 39±2°°
FeS-NO, g = 2.03 5.3 ± 0.2 6.6±0.4** 6.3±0.4*
Transferrin 32.4 ± 1.9 22.3±1.3*** 26.5±2.6
Oxidized Ceruloplasmin 21.1 ± 0.3 23.8±0.4*** 21.2±0.9°
MDA, µmol/g wet tissue 40.0 ± 2.0 44±3 44±2
ATP, µmol/g wet tissue 1.83 ± 0.15 1.36±0.07 1.56±0.09
Cytochrome C, nmol/g wet  tissue 8.2 ± 0.3 6.6±0.2*** 6.7±0.2***
Lactate, mmol/g wet  tissue 1.12 ± 0.12 1.19±0.07 1.45±0.16
Pyruvate, mmol/g wet  tissue 0.075 ± 0.008 0.065±0.004*** 0.15±0.07***°°°
Lactate/Pyruvate 19.9 ± 3.3 19.5±1.9 18.1±2.1
NADH-ubiquinone reductase, µmol/(mg of protein × min) 23.4 ± 0.8 17.4±0.5*** 30.7±9.2***°°°
Succinate-ubiquinone reductase, µmol/(mg protein × min) 1.27 ± 0.06 0.88±0.04*** 0.91±0.06***
SDH, nmol/mg protein 58.0 ± 2.0 55±2 59±4
Endothelin-1, fg/mg protein 1.30 ± 0.08 2.58±0.27*** 1.25±0.09°°°
Note: the significance of differences in average values: when compared with the indicator of the intact group – * p<0.05, ** p<0.01, *** p<0.001; 
when compared with the indicator control group (periodontitis) – ° p<0.05, °° p<0.01, °°° p<0.001.
Figure 2. Edema, plethora, foci of hemorrhages, fibrinoid 
changes in the walls of blood vessels, thick polymorphic cel-
lular infiltration in the reticular zone of the gingiva. Mast 
cells in the composition of the infiltrate (Stained with alde-
hyde-fuchsin-chromotrope-aniline blue, ×200)
Figure 3. Acantosis. Inflammatory cellular infiltrate (Stained 
with hematoxylin and eosin, ×400)
the lamina propria of the gingival mucosa and came in 
contact with inflammatory cellular infiltrate (Fig. 5).
The thickness of the epithelial layer was 376±18 mi-
crons. A diapedesis of neutrophilic granulocytes was ob-
served in hyperplastic epithelial tissue. As a result of focal 
accumulations of neutrophils, there appeared foci of suppu-
ration with the melted superficial areas of the epithelial lay-
er, which led to erosion of the mucous membrane (Fig. 6).
Alterative changes in the form of vacuole and even bal-
looning degeneration were often detected in the epithelial 
covering (Fig. 6). At the same time, foci with dystrophical-
ly altered cells were near the morphologically intact areas 
of the mucosa. The same cell focality was characteristic of 
the areas of excessive keratinization of the superficial areas 
of the epithelial covering (Figs. 7 and 8). Dyskeratosis of 
individual cells and their complexes was detected (Fig. 8).
The	results	of	the	14-day	ST	in	animals	with	EP	(com-
parison	group). In this group, the effectiveness of the 14-
day course of ST (without the use of BFC) was morpho-
logically evaluated in the study of biopsy specimens 28 
days after the start of ST. In the lamina propria of the gin-
gival mucosa, all signs of edema were completely stop-
ped; there were neither hemorrhages, nor fibrinoid chan-
ges of blood vessels and connective tissue. In the area of 
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Figure 4. Acantosis. Massive inflammatory cellular infiltrate. 
Vacuolar dystrophy of gingival epithelial cells (Stained with he-
matoxylin and eosin, ×100).
Figure 5. Rete acantotic pegs in contact with thick inflammatory 
cellular infiltrate (Stained with hematoxylin and eosin, ×100)
Figure 6. Acantosis. Leucodiapedesis in the thickened epithelial 
layer. Multiple abscesses formed in the superficial area of the 
epithelial layer with the eroded mucous membrane (indicated 
with red arrows) (Stained with hematoxylin, ×100)
Figure 7. Vacuole and ballooning degeneration of epitheli-
al cells. Areas of dyskeratosis (indicated with blue arrows) 
(Stained with alcian blue–neutral red, ×400)
Figure 8. Acantosis. Excessive keratinization of the superficial 
areas of the epithelial covering (corneous masses are colored 
red). Vacuole degeneration of epithelial cells (“wicker basket”) 
(Stained with aldehyde-fuxin-chromotrope-aniline blue, ×100)
Figure 9. Compact lymphohistiocytic infiltrates among fields of 
proliferative fibrous connective tissue (Stained with alcian blue 
with neutral red, ×100)
massive cellular infiltrate, strands of fibrous connective 
tissue were formed (Fig 9); therefore, the area of scle-
rotic tissues increased 8.5 times (Table 5). A significant 
decrease in the thickness of the gingival epithelial cove-
ring was recorded; in it, however, there remained areas of 
impaired keratinization with accumulated oxyphilic and 
PAS-positive substances, as well as dystrophic changes in 
the siperficial epithelium cells (Fig. 10).
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Thus, under the influence of ST in the lamina propria 
of the gingival mucous membrane, there was observed 
positive dynamics in the treatment. However, at the same 
time incomplete regeneration of recovering tissues clearly 
prevailed. Sclerotic tissue was detected on the area, which 
accounted for more than 45% of the entire reticular layer.
The	 results	 of	 the	 14-day	 ST+BFC	 in	 animals	 with	
EP	(main	group). In this group of animals, as a result of 
adding BFC to the complex of ST treatment measures, a 
more favorable effect was obtained, which affected the re-
generative processes in the gingiva as compared with only 
the basic ST. Along with reverting morphological signs of 
inflammation, an ability of BFC to enhance angiogenesis 
became apparent. At the same time, adding BFC to phar-
macotherapy of rats with EP resulted in the vasculariza-
tion index increasing more than 2.9 times (Table 5). The 
resulting regenerate contained a network of newly formed 
blood vessels (Figs. 11–13), which contributed to the ac-
tivation of high-level metabolic processes in the tissues of 
the regenerate and eliminated hypoxia.
Due to such changes, the structure of the gingival 
epithelial covering was normalized, and dystrophic pro-
cesses in epithelial cells were effectively eliminated. The 
thickness of the epithelial covering decreased 2.2 times in 
comparison with this indicator in the group before treat-
ment, and the character of keratinization also became nor-
mal. Along with the areas of incomplete regeneration with 
proliferative nonspecific fibrous tissue, almost throughout 
the entire network of the reticular layer, significant areas 
were constantly detected, restored by the full regeneration 
type, i.e. loose connective tissue was formed, identical to 
that which had been there before it was damaged initially 
(Figs. 14–15).
BFC, additionally included in ST, determined the com-
plete restoration of the structure of the normal gingival 
reticular layer in the area of 31.5±3.2%. The area of scle-
rotic fields without BFC was 45.0±3.3%, whereas with 
the addition of BFC, this indicator decreased more than 
1.6 times (Table 5). These data are objective evidence that 
there is a possibility in principal to considerably increase 
by means of BFC the share of full regeneration in the gin-
gival connective tissue basis with the normalization of the 
morphology of its epithelial covering.
Thus, when carrying out morphological studies, BFC 
was found to act as a stimulant and corrector for restorative 
processes in the gingiva. In combination with ST, it stimu-
lates angiogenesis, increasing vascularization of the regen-
erate 2.9 times, which ensured the delivery of necessary 
substances to regenerating tissues. The developed vascular 
network served as a source for supplying regenerating tis-
Table 5. The Results of Morphometric Studies of Gingival Biopsy Specimens in Treatment of EP in rats (M±m, n = 15)
Groups of animals Average thickness of 
the epithelial covering 
of gingiva, µm
Area of the vascular 
bed in the reticular 
layer of gingiva,%
Total area of cellular 
infiltrates in the 
gingival connective 
tissue base,%
Total area of sclerotic 
tissue in gingiva,%
Total area of the 
connective tissue basis 
of gingiva, restored by 
restitution type ,%
Before Treatment (1) 376 ± 18 5.1 ± 0.4 87.2 ± 8.4 5.3 ± 0.8 –
ST (2) 254 ± 22 5.2 ± 0.5 44.4 ± 4.0 45.0 ± 3.3 5.1 ± 1.4
р1-2 < 0.001 р1-2 > 0.5 р1-2 < 0.001 р1-2 < 0.001
ST+BFC (3) 171 ± 21 14.9 ± 1.3 26.6 ± 2.5 27.0 ± 1.4 31.5 ± 3.2
р1-3 < 0.001 р1-2 < 0.001 р1-3 < 0.001 р1-3 < 0.001 р2-3 < 0.001
р2-3 < 0.001 р2-3 < 0.001 р2-3 < 0.001 р2-3 < 0.001
Figure 10. Vacuole degeneration of epithelial cells. Increased 
content of PAS-positive substances in them (stained with hema-
toxylin and according to Hotchkiss-McManus’ method, ×200)
Figure 11. Pronounced vascularization of cellular infiltrates 
separated by strands of fibrous connective tissue. In the lower 
right corner, there is loose connective tissue in the area of resti-
tution (Stained with alcian blue and neutral red, ×100)
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sues with specialized fibroblasts capable of creating a con-
nective tissue matrix, similar to that before its damage by 
the inflammatory process (Serov et al. 1998). At the same 
time, the capacity of tissues for a more perfect, namely, or-
ganotypic regeneration of the mucosal lamina	propria (its 
share increased 6.2 times) was more pronounced in combi-
nation with the reduction of alterative manifestations in the 
epithelial covering. Under the influence of ST only (without 
BFC), regeneration in the gingiva was mainly characterized 
by the replacement of damaged tissues with nonspecific fi-
brous tissue, which eliminated neither trophic disturbances, 
nor the hypoxic effects on the superficial epithelium.
Special emphasis should be laid on the fact that the 
studies based on the analysis of morphological criteria 
made it possible for the first time to establish that BFC 
has a pronounced angioprotective effect and also stimu-
lates the processes of full regeneration; at the same time 
the ability of the damaged gingival tissues to restore the 
typical (original) structure of the ginfival mucosa lami-
na propria increases along with the normalization of the 
structure of its epithelial covering.
The influence of BFC and glibenclamide on the indices 
of hypoglycemic activity in the GTT
In the animals of the control group, the fasting blood 
glucose concentration was 4.37±0.32 mmol/L. With 
GTT, the highest level of glycemia was observed 30 
minutes after the administration of glucose and was 
11.98±0.71 mmol/L, which is statistically significantly 
2.7 times higher than the initial level. After 60 min, the 
concentration of glucose in blood decreased to 9.49±0.63 
mmol/L, which was significantly 1.3 times lower than the 
previous measurement of glucose concentration and 2.2 
Figure 12. The network of newly formed small blood vessels 
in the composition of the formed regenerate (Stained with alde-
hyde-fuchsin-chromotrope-aniline blue, ×200)
Figure 13. Multiple vascular lumes in the area of the reticular 
layer, restored by the full regeneration type (Stained with hema-
toxylin and eosin, ×100)
Figure 14. Vascularized restitution area in the gingival reticular 
layer. In the loose connective tissue, the main substance clear-
ly dominates over the fibrous structures (Stained with alcian 
blue-neutral red, ×200)
Figure 15. Loose connective tissue in the focus of complete re-
generation (stained with alcian blue with neutral red, ×200)
Galenko-Yaroshevsky PA et al.: Benzofurocaine: effects on experimental periodontitis ...26
times higher than the initial level. After 120 min, the con-
centration of glucose in blood was 5.97±0.47 mmol/L, 
and compared with the initial level, it was significantly 
1.4 times higher. A.A. Pokrovsky’s coefficient (Buzlam et 
al. 2013) was found to be 174.1, which indicates glucose 
intolerance.
When glibenclamide (0.36 mg/kg) was used, 60 min-
utes after its administration, there was a statistically 
significant 1.3-fold decrease in fasting blood glucose (to 
4.45±0.48 mmol/L) compared with the baseline values 
(5.90±0.49 mmol/L). Under GTT conditions, 30 min-
utes after glucose administration, the glycemia level 
was significantly 1.4 times lower compared to the ab-
solute value of the corresponding indicator in the con-
trol (8.63±0.62 mmol/L versus 11.98±0.71 mmol/L). 
After 60 and 120 minutes, affected by glibenclamide, 
when compared with the control data in absolute values 
(6.25±0.42 and 3.87±0.19 mmol/L versus 9.49±0.63 and 
5.97±0,47 mmol/L), glycemia was significantly 1.52 and 
1.54 times less. A.A. Pokrovskiy’s coefficient turned out 
to equal 46.3, which shows that  glibenclamide elimi-
nates glucose tolerance.
BFC at doses of 5 and 10 mg/kg 60 minutes after the in-
jection reduced (by 18.8 and 15.1%, respectively) fasting 
blood glucose. With GTT 30 minutes after the adminis-
tration of glucose, the glycemia level became 1.4 and 1.5 
times lower than the absolute value of the corresponding 
indicator in the control (8.64±0.69 and 7.92±0.39 mmol/L 
versus 11.98±0.71 mmol/L) and 146.0 and 140.0% low-
er than the initial value. After 60 minutes, affected by 
BFC, when compared with the control by absolute val-
ues (7.50±0.70 and 6.50±0.34 mmol/L versus 9.49±0.63 
mmol/L), glycemia was significantly 1.3 and 1.5 times 
(or by 21.0 and 31.5%) less, and after 120 minutes – was 
hardly  different from the control. Pokrovsky’s coefficients 
when using BFC at doses of 5 and 10 mg/kg, respectively, 
were 43.5 and 52.9, which indicates the decreasing influ-
ence of this drug on glucose tolerance.
The effect of BFC on glucose concentration in plasma 
of rats with experimental diabetes
The level of blood glucose after the 30th day of develop-
ment of diabetes was 27.9±2.55 mmol/L (n = 16, p<0.05), 
and after the 90th – 32.6±0.38 mmol/L (n = 16), which 
is significantly higher (p<0.05) than that in the  intact 
animals (6.7±0.38 mM/L, n = 8). On Days 2, 4, and 5 , 
BFC contributed to a significant decrease in the level of 
glucose (Fig. 15). The injection of BFC did not affect the 
blood glucose level of rats after the 90th day of develop-
ment of diabetes (Fig. 16).
A study of endothelium-dependent dilatation of isola-
ted aortic preparations showed that the application of AC 
at a concentration of 10-10 – 3×10-5 mmol/L caused a do-
se-dependent dilation of isolated aortic preparations with 
a maximum dilatation of 96.5±3.05% of the preconstric-
tion of the preparations caused by PE at a concentration 
of 10-6 mmol/L (n = 8) (Fig. 17). The value of pD2 was 
7.59±0.08 (n = 8).
In the aorta preparations of rats with experimental 
diabetes, there was a significant suppression of endot-
helium-dependent dilatation on AC with a maximum of 
76.88±3.98% (n = 8, p<0.05) with a duration of diabetes 
of 30±7 days (Fig. 17) and 78,05±5.57% (n = 8, p<0.05) 
with the duration of diabetes 90±7 days (Fig. 17). The 
value of pD2 with respect to the control decreased to 
7.13±0.09 (n = 8, p<0.05) and 6.7±0.18 (n = 8, p<0.05). 
The shift of the dose-response curve, characterized by the 
pD2parameter, is an indicator of the changing sensitivity 
of vascular preparations to the action of the test substan-
ce. In this case, the curve shifts to the left.
Figure 16. Blood glucose level in rats (control), diabetic ani-
mals on the 30th and 90th day after administration of streptozoto-
cin, diabetic rats after the course of administration of BFC (dia-
betes 30 days + BFC; diabetes 90 days + BFC). Note: # p<0.05 
with respect to the control, * p<0.05 with respect to diabetic rats.
Figure 17. Dilator reactions of isolated rat aorta segments, pre-
viously contracted by PE (10-6 mmol/L), under the influence of 
AC (10-10–3×10-5 mmol/L) in aorta of control animals (control), 
diabetic animals at early stages of the development of diabetes 
(diabetes 30 days) and diabetic animals after the course of ad-
ministration of BFC (diabetes 90 days + BFC). Note: * p <0.05 
with respect to the control
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The course administration of BFC did not cause chan-
ges in the maximum amplitude of endothelium-dependent 
dilatation of aortic preparations of diabetic rats under the 
influence of AC at the early stages (Fig. 17) and at the 
later stages of the development of diabetes (Fig. 18). The 
maximum vasodilation in this case was 77.53±7.64 (n = 
8, p<0.05) and 78.39±7.95% (n = 8, p<0.05), respectively. 
At the same time, an increase in the pD2 value to 7.57 
± 0.19 (n = 8, p>0.05) was observed at the early stages 
of the development of diabetes, which had no significant 
differences from the indicators of healthy animals, and to 
7.05±0.21 (n = 8, p<0.05) at the later stages of the deve-
lopment of diabetes.
The data obtained indicate that the course introduction 
of BFC to diabetic animals does not affect the maximum 
amplitude of the  endothelium-dependent aortic dilatation 
suppressed in conditions of DM; however, it increases the 
sensitivity of the aorta to the action of AC. It should be 
noted that the positive effect of BFC depends on the dura-
tion of the development of diabetes.
Total outward K+-current isolated SMC of aorta was 
studied on diabetic animals after the 30th day of the injec-
tion of streptozotocin. The total outward K+-current was 
recorded in response to the step-by-step depolarization of 
the isolated SMC membrane from -100 to 70 mV every 
3 seconds at a maintained potential of -60 mV. The total 
outward K+-current in the SMC of control animals with a 
maximum membrane depolarization level of –70 mV was 
51.4±4.76 pA/pF (n = 8). The density of the outward cur-
rent in the aortic SMC of diabetic animals was lower than 
in the control and was 18.1 ± 1.84 pA/pF (n = 10, p<0.05). 
The course injection of BFC did not cause changes in the 
density of the outward  K+-current, which at the maxi-
mum depolarization level of -70 mV did not differ from 
the indicators of the diabetic animals and was 17.8±1.38 
pA/pF (n = 14, p> 0.05) (Fig. 19).
Conclusion
The use of the combination of BFC with ST in rats with 
EP has a pronounced therapeutic effect both in the short-
term (on the 11th day) and long-term periods after treat-
ment (after 1 month), significantly exceeding ST, carried 
out separately.
In case of healthy periodontium, BFC reduces the flow 
of erythrocytes and its variability in the capillary bed of 
AG of lower incisors in rats; at the sme time while vaso-
motor activity remains stable compared to the baseline, 
which may be due to an increase in total peripheral vas-
cular resistance.
The use of the combination of BFC with ST in EP 
causes a significant increase in microcirculation in AG of 
rats, both immediately after the 12-day treatment and 1 
month after its completion, with microcirculation reach-
ing the level like it was before periodontitis simulation, 
while when used separately, ST induces an increase in 
microcirculation in the selected area only after treatment, 
whereas microcirculation decreases 1 month later.
The improvement of the dental status and a decrease 
in the periodontal index in rats with EP affected by BFC 
course administration is accompanied by normalization of 
the prekallikrein-kallikrein system, and a decrease in the 
synthesis of bradykinin. The anti-inflammatory effect of 
BFC may be due to a decrease in the level of pro-inflam-
matory cytokines and PGE2; there is a close relationship 
between the levels of the latter and bradykinin. BFC sig-
nificantly increases the level of VEGF and reduces that of 
vasoconstrictor endothelin-1, which may indicate stimu-
lation of the growth of lymphatic vessels and the capillary 
network in periodontal tissues.
Using BFC, which has a pronounced anti-inflammatory 
effect, along with inhibiting COX-2 and anti-bradykinin 
activity, in the treatment of periodontitis, will help elimi-
Figure 19. Volt-ampere characteristic of the total outward 
K+-current membrane of isolated aortic SMC of control rats 
(control), diabetic animals after the 30th day of development of 
diabetes (diabetes) and diabetic animals after the course admin-
istration of BFC (diabetes + BFC). Note: * p <0.05 in compari-
son to the control
Figure 18. Dilator reactions of isolated rat aorta segments pre-
viously reduced by PE (10-6 mmol/L), under the influence of 
AC (10-10–3×10-5 mmol/L) in aorta of control animals (control), 
diabetic animals at later stages of the development of diabetes 
(diabetes 90 days) and diabetic animals after the course of ad-
ministration of BFC (diabetes of 90 days + BFC). Note: * p < 
0.05 in comparison to the control
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nate neurohumoral imbalance of interleukin-1, thrombox-
ane A2, TNF-α, endothelin-1 and prostaglandins.
BFC has a positive effect on the energy supply system 
of periodontal tissues, increasing the ATP content and ac-
tivating NADH-ubiquinone reductase, and also stimulat-
ing the processes of aerobic glycolysis in rats with EP. The 
drug reduces the intensity of hypoxic syndrome, which is 
due to its antioxidant activity – the ability to suppress the 
generation rate of superoxide anion, hydrogen peroxide, 
to reduce the content of nitrosothiols and NO metabolites 
(NO2/NO3), and to increase the level of transferrin.
BFC in combination with ST in rats with EP stimulates 
angiogenesis, increases vascularization of the regenerate, 
which ensures the delivery of necessary substances to the re-
generating tissues. At the same time, the developed vascular 
network serves as a source supplying the regenerating tissues 
with specialized fibroblasts which create a connective tissue 
matrix, similar to that before its damage by the inflammatory 
process. In this context, the ability of the tissue to more per-
fect organotypic regeneration of the mucosal lamina propria 
in combination with reduction of alterative manifestations in 
the epithelial covering is more pronounced. ST, carried out 
separately (without BFC), causes, as a rule, sclerotic chang-
es, with no normalization of the morphofunctional state of 
the gingival epithelial cover occuring.
BFC, when GTT is made in mice, like glibenclamide, 
is capable of reducing the blood glucose level, but the de-
grees of hypoglycemic effect of BFС and glibenclamide 
are different, with glibenclamide having a more pro-
nounced effect. In intact animals, BFC has no significant 
effect on fasting blood glucose levels; the detected hypo-
glycemic effect of the drug in GTT should be regarded as 
normoglycemic.
In streptozotocin diabetes in rats, BFC has a hypogly-
cemic effect on early diabetes (30 days), while it tends 
to restore endothelium-dependent dilatation of the aortic 
SMC; has no significant effect on these indicators during 
late periods of diabetes (90 days) and has no effect on 
the functioning of the K+-channels of the aortic SMC 
during both periods of the study. The hypoglycemic ef-
fect of BFC may be due to its antioxidant, antihypoxant 
and anti-inflammatory properties, as well as its ability 
to increase the activity of NAD and NADPH-dependent 
β-cells of islets of Langerhans.
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